(Q37318979)

19 August 2017

Treatment-subgroup interaction: an example from a published, phase II clinical trial (English)

1 reference

19 August 2017

phase II clinical trial

0 references

author name string

Carolyn E Behrendt

series ordinal

1

1 reference

19 August 2017

Edmund A Gehan

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

21 February 2009

1 reference

Contemporary Clinical Trials

19 August 2017

1 reference

19 August 2017

30

1 reference

19 August 2017

3

1 reference

19 August 2017

279-281

1 reference

Bayesian designs to account for patient heterogeneity in phase II clinical trials

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732105

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732105

Optimal two-stage designs for phase II clinical trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732105

Accounting for patient heterogeneity in phase II clinical trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2732105

A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia

2 September 2018

1 reference

12 December 2020

Prediction of remission in adult acute leukemia: development and testing of predictive models

1 reference

12 December 2020

The evaluation of therapies: historical control studies

1 reference

12 December 2020

A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia

1 reference

12 December 2020

Optimal and minimax three-stage designs for phase II oncology clinical trials

1 reference

12 December 2020

10.1016/J.CCT.2009.02.002

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19232549

1 reference